ScholarWorks@SOONCHUNHYANG UNIVERSITY: Suh, Jon

Detailed Information

Suh, Jon (서존)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Percutaneous coronary intervention:3||STEMI:2||Undergoing Primary Percutaneous Coronary Intervention:2||Metabolic syndrome:2||acute coronary syndrome:2||acute myocardial infarction:2||percutaneous coronary intervention:2||Myocardial infarction:2||순환기내과:2||Radial artery:2||INTERSTELLAR Registry:2||Cardiac reverse remodeling:1||Cardiac rhythm monitoring:1||Cilostazol:1||Clinical outcome:1||Clonal hematopoiesis:1||Combined Dysglycemia:1||ContrastInduced Acute Kidney Injury:1||Coronary angiography:1||Coronary artery disease:1||Cutting balloon:1||DM in patients with CAD:1||Diet:1||East Asians:1||Exercise:1||Heart failure:1||Heart, CT:1||Heart, US:1||Highthroughput nucleotide sequencing:1||Hypertension.:1||Hypoxic Liver Injury:1||HypoxicLiver Injury:1||Incidence:1||Inflammation:1||Intravascular ultrasonography:1||Korea:1||LDL:1||Life style:1||Longitudinal contractile reserve:1||Lymphangiomatosis:1||MACCE:1||Myonecrosis:1||National Health Insurance Service (NHIS):1||Neovascularization and Associated Fistula Formation in a Left Atrial Myxoma: Evaluation with Multidetector Computed Tomography.:1||Percutaneous transluminal coronary angioplasty:1||Performance of JCTO and PROGRESS CTO Scores in Predicing Angiographic Success and Longterm Outcomes of Percutaneous Coronary Interventions for Chronic Total Occlusions:1||Platelet:1||Preventive Strategies of Renal Insufficiency:1||PrimaryPercutaneous Coronary Intervention:1||Prognosis:1||Prognostic:1||Prognostic Impact:1||Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention:1||Registries:1||Relation of Stature:1||Renal Infarction:1||Renal infarction:1||Reninangiotensinaldosterone system:1||SENSFP:1||ST Elevation Myocardial Infarction:1||ST elevation myocardial infarction:1||STSegment Elevation Myocardial Infarction:1||STsegment elevation myocardial infarction:1||Smoking:1||South Korea:1||Stents:1||Thrombosis:1||Transcriptome:1||Triple antiplatelet therapy might be a better antiplatelet regimen than dual antiplatelet therapy for patients with STsegment elevation myocardial infarction. Although this benefit was strong in patients aged <75 years:1||Worsening heart failure:1||aging:1||angiography:1||betablocker:1||biomarker:1||blood flow velocity:1||cardiovascular disease:1||cardiovascular diseases:1||cholesterol:1||chronic total occlusion:1||computed tomographic angiography:1||coronary artery disease:1||coronary atherosclerosis:1||coronary reperfusion:1||deescalation strategy:1||dialysis:1||doortoballoon time:1||drug combinations:1||drugeluting stent:1||everolimuseluting stent:1||exosome:1||ezetimibe:1||femoral artery:1||height loss:1||hemometabolic risk factors:1||hypoxic hepatitis:1||hypoxic liver injury:1||inhospital mortality:1||intravascular ultrasonography:1||microRNA:1||microvascular angina:1||mortality:1||multidetector computed tomography:1||myocardial fractional flow reserve:1||myocardial infarction:1||no definite increase in major bleeding was seen for elderly patients (aged ≥75 years).:1||noncompliant balloon:1||platelet function test:1||postdilatation:1||prasugrel:1||primary percutaneous coronary intervention:1||probability:1||prognosis:1||radial artery:1||rosuvastatin calcium:1||sensitivity and specificity:1||shock:1||급성 심근 경색:1||베체트병:1||ACE inhibitors:1||심장내 혈전증:1||Acute coronary syndrome:1||Alcohols:1||Allcause mortality:1||Angiotensin receptor blocker:1||Angiotensin receptorneprilysin inhibitor:1||Atrial fibrillation:1||Behçet’s syndrome:1||Bradykinin:1||CVD:1||Calcification:1||

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE